Carlsmed

$Carlsmed(CARL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-26-009828  Act: 34  Size: 178 KB 网页链接

$Carlsmed(CARL)$ B Capital集团及相关实体提交的Schedule 13G文件披露了其在Carlsmed公司的持股情况。B Capital Global Growth III, L.P.直接持有5,013,839股（18.9%），B Capital Healthcare I, L.P.持有2,376,472股（8.9%），Hornet Co-Invest, L.P.持有931,452股（3.5%）Carlsmed普通股。作为G...

$Carlsmed(CARL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-032076  Size: 4 KB 网页链接

$Carlsmed(CARL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-032071  Size: 4 KB 网页链接

2023年第四季度，卡尔利斯公司(CARL)报告利润下滑，较去年同期下降12%，主要归咎于原材料成本上升与供应链中断。公司股票在盘后交易中下跌5%。工业与商业部门成本增加，导致利润下滑。预计2026年第一季度，公司利润率将持续承压。截至今日，CARL股价已下跌10%，反映市场对财务健康状况的担忧。...

$Carlsmed(CARL)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-280220  Act: 34  Size: 116 KB 网页链接

$Carlsmed(CARL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-032069  Size: 4 KB 网页链接

$Carlsmed(CARL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-032073  Size: 4 KB 网页链接

$Carlsmed(CARL)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-282898  Act: 34  Size: 130 KB 网页链接